title: Effect of postoperative mydriatics on the iris.
abstract: OBJECTIVE
  To assess the role postoperative mydriatics play after extracapsular cataract extraction (ECCE) and posterior chamber intraocular lens (IOL) implantation in causing iris modifications and in controlling inflammation.
  
  
  METHODS
  Outpatients Department, Ninewells Hospital, Dundee, Scotland.
  
  
  METHODS
  The prospective study comprised 136 patients who had standardized ECCE. Half the patients used a mydriatic for 2 weeks postoperatively. Anterior chamber activity, pain, and eye redness were evaluated at 2 weeks postoperatively; pupil shape, peripheral anterior synechias, IOL position, and iris adhesions, at 6 weeks.
  
  
  RESULTS
  Iris-lens adhesions were significantly more common in the group using a mydriatic. There was no difference between the two groups in postoperative inflammation.
  
  
  CONCLUSIONS
  Mydriatics should not be used routinely after ECCE with posterior chamber IOL implantation.
authors.affiliation: Ophthalmology Department, Ninewells Hospital and Medical School, Dundee, Scotland.
authors.forename: S
authors.initials: S
authors.lastname: Ahmed
authors.forename: P
authors.initials: P
authors.lastname: Mann
authors.forename: A
authors.initials: A
authors.lastname: Gaskell
authors.forename: S
authors.initials: S
authors.lastname: Roxburgh
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D001623:Betamethasone / Q000008:administration & dosage / Q000031:analogs & derivatives; D002387:Cataract Extraction; D003519:Cyclopentolate / Q000009:adverse effects*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007498:Iris / Q000187:drug effects*; D007499:Iris Diseases / Q000139:chemically induced*; D007910:Lenses, Intraocular; D008297:Male; D008875:Middle Aged; D009184:Mydriatics / Q000009:adverse effects*; D009355:Neomycin / Q000008:administration & dosage; D009883:Ophthalmic Solutions; D011183:Postoperative Complications / Q000139:chemically induced*; D011446:Prospective Studies; D000267:Tissue Adhesions / Q000139:chemically induced
chemical_list: D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D009184:Mydriatics; D009883:Ophthalmic Solutions; C081596:betamethasone, neomycin drug combination; D001623:Betamethasone; D009355:Neomycin; D003519:Cyclopentolate